First Report® Conference Coverage

First Report® Conference Coverage

group of doctors nurses

At its 2017 Annual Meeting, the American Geriatrics Society celebrated its 75th anniversary—three-quarters of a century pursuing its mission to provide leaders in geriatric medicine, advocate for patient-centered care policies, and advance geriatric research and care delivery.


The 2016 AHA Scientific Sessions discussed cutting-edge cardiovascular clinical practice from basic, clinical, population, and translational perspectives. 

The American Society of Consultant Pharmacists (ASCP) is devoted to optimal medication management and improved health outcomes for older adults.


The theme of IDWeek was “Advancing Science, Improving Care” and featured the latest science and bench-to-bedside approaches of infectious diseases.

The ICS Annual Meeting, unique in its multidisciplinary focus on continence, brings together health care professionals from the fields of urology, gynecology, physiotherapy, and nursing to discuss the latest breakthroughs in the management of continence-related health issues.

Researchers from Japan assessed the efficacy and safety of fesoterodine vs placebo (PBO) in elderly females with OAB symptoms, including urgeny urinary incontinence (UUI) and with or without concomitant HT in a post-hoc analysis.

One study presented by researchers at the ICS Conference evaluated the effect of comprehensive PFMEs on UI symptoms in older women with cognitive impairment; the study consequently won the Conservative Management Award. 

Another study at the ICS Confererence aimed to explore the nature and mechanisms of behavioral changes made by community-living older women following attendance of a bladder health and continence promotion workshop to support self-management and to reduce severity of lower urinary tract symptoms (LUTS).

One team of researchers at ICS 2016 sought to qualitatively explore the opinions of residents, family members, staff, and continence practitioners, about “quality continence care” in LTCFs.

Findings from a study presented at AAIC 2016 suggest that dementia treatment, specifically in older adults with severe comorbidities, can result in lower all-cause health care costs and lower mortality rates compared with untreated patients.